Trials / Completed
CompletedNCT04336566
Renal Effects of Melatonin Trial in Chronic Kidney Disease
Renal Function in Chronic Kidney Disease and the Effect of Exogenous Melatonin Administration (REM TRIAL)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- University of Oklahoma · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This will be a prospective, double blinded, randomized, controlled pilot study to determine if there is any correlation between melatonin administration and proteinuria.
Detailed description
Investigators plan to enroll up to 100 eligible participants in this pilot trial with 50 participants randomized to receive melatonin and 50 patients randomized to receive a placebo. Participants will be randomized on a rolling basis; meaning, once participants agree to enroll in the study, the participant will be placed randomly into either group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Melatonin | Melatonin 5mg |
| DIETARY_SUPPLEMENT | Placebo | Comparable Good Neighbor Pharmacy placebo tablet |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2020-05-13
- Completion
- 2020-05-13
- First posted
- 2020-04-07
- Last updated
- 2020-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04336566. Inclusion in this directory is not an endorsement.